| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | ― | ― | ― | ― | ― | ― | |
75 Outperform | £2.05B | 1.18 | 24.73% | 1.18% | 7.17% | -2.22% | |
66 Neutral | £1.54B | 4.77 | 6.46% | ― | 3.87% | 18.87% | |
64 Neutral | £249.24M | 15.55 | 5.43% | 1.39% | -5.30% | -30.17% | |
61 Neutral | £132.52M | 7.55 | 9.72% | 0.60% | 3.16% | -21.30% | |
56 Neutral | £678.96M | 8.84 | -113.93% | 1.40% | 3.94% | ― | |
48 Neutral | £1.25B | -26.58 | -59.21% | 2.50% | 5.98% | -371.14% |